DCM
ALDR

Driehaus Capital Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Driehaus Capital Management’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-232,874
Closed -$7.63M – 700
2016
Q3 		$7.63M Buy
232,874
+79,431
+52% +$2.42M 0.26% 83
2016
Q2 		$3.83M Buy
+153,443
New +$4.15M 0.14% 161
2015
Q4 		– Sell
-66,716
Closed -$2.19M – 677
2015
Q3 		$2.19M Sell
66,716
-14,691
-18% -$625K 0.08% 270
2015
Q2 		$4.31M Sell
81,407
-16,019
-16% -$583K 0.15% 167
2015
Q1 		$2.81M Sell
97,426
-1,404
-1% -$38.5K 0.1% 262
2014
Q4 		$2.88M Buy
98,830
+3,108
+3% +$55.8K 0.12% 235
2014
Q3 		$1.21M Sell
95,722
-2,087
-2% -$31.5K 0.05% 405
2014
Q2 		$1.96M Buy
+97,809
New +$1.38M 0.06% 349

Other funds holding ALDR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return